Literature DB >> 12610810

The structure and histopathology of the "enthesis organ" at the navicular insertion of the tendon of tibialis posterior.

Bernhard Moriggl1, Tsukasa Kumai, Stefan Milz, Michael Benjamin.   

Abstract

OBJECTIVE: To investigate the structure, histopathology, and molecular composition of tissue specializations of the tibialis posterior enthesis. They collectively reduce stress concentration at the insertion site and are part of an "enthesis organ." This has implications for understanding the basis of enthesopathy.
METHODS: Fifty-two specimens of tibialis posterior and the associated superomedial part of the calcaneonavicular ligament taken from cadavers were sectioned longitudinally and examined by routine histology (42 samples) or immunohistochemistry (10 samples). Serial sections of formalin fixed material were stained with Masson's trichrome, toluidine blue, or hematoxylin, eosin and alcian blue. A panel of antibodies against collagens, glycosaminoglycans, and proteoglycans was used to immunolabel methanol fixed material.
RESULTS: The enthesis organ consists of the enthesis itself, the superomedial part of the calcaneonavicular ligament (which may fuse with the tendon), the tendon sheath, and associated accessory bones. The accessory bones lay in a region of fibrocartilage that was present even in specimens where the bones themselves were absent. Degenerative changes were seen at the enthesis, around the accessory bones, and in the walls of the tendon sheath. The navicular and accessory bone entheses, together with the calcaneonavicular ligament, were all rich in fibrocartilage. This immunolabeled for aggrecan, link protein, type II collagen, and versican.
CONCLUSION: The complexity of the enthesis organ, and the diversity of sites showing histopathological changes, suggest that enthesopathy may not be located precisely at the osteotendinous junction. It could target a number of adjacent locations, in accord with what happens at other entheses; e.g., in patients with spondyloarthropathy. The prominence of fibrocartilage in the enthesis organ, and the degenerative changes to which it is subject, support the view that spondyloarthropathy has an underlying biomechanical basis.

Entities:  

Mesh:

Year:  2003        PMID: 12610810

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Adipose tissue at entheses: the rheumatological implications of its distribution. A potential site of pain and stress dissipation?

Authors:  M Benjamin; S Redman; S Milz; A Büttner; A Amin; B Moriggl; E Brenner; P Emery; D McGonagle; G Bydder
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

Review 2.  Where tendons and ligaments meet bone: attachment sites ('entheses') in relation to exercise and/or mechanical load.

Authors:  M Benjamin; H Toumi; J R Ralphs; G Bydder; T M Best; S Milz
Journal:  J Anat       Date:  2006-04       Impact factor: 2.610

3.  Posterior tibialis tendonopathy in an adolescent soccer player: a case report.

Authors:  Erik A Yuill; Ian G Macintyre
Journal:  J Can Chiropr Assoc       Date:  2010-12

4.  Fluid around the distal tibialis posterior tendon on ankle MRI: prevalence and clinical relevance.

Authors:  Sangoh Lee; Ines Oliveira; Yueyang Li; Matthew Welck; Asif Saifuddin
Journal:  Br J Radiol       Date:  2019-10-17       Impact factor: 3.039

5.  Tibialis posterior tenosynovitis and associated pes plano valgus in rheumatoid arthritis: electromyography, multisegment foot kinematics, and ultrasound features.

Authors:  Ruth Barn; Deborah E Turner; Daniel Rafferty; Roger D Sturrock; James Woodburn
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

6.  Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy.

Authors:  Anthony N Corps; Andrew H N Robinson; Rebecca L Harrall; Nicholas C Avery; Valerie A Curry; Brian L Hazleman; Graham P Riley
Journal:  Ann Rheum Dis       Date:  2012-01-12       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.